JP Morgan Cazenove Maintains Smiths Group (LON:SMIN) As Overweight; Has Price Objective Of GBX 1600.00

Smiths Group (LON:SMIN) Rating

London: In analysts report revealed to clients and investors on Thursday, 29 September, JP Morgan Cazenove reaffirmed their Overweight rating on shares of Smiths Group (LON:SMIN). They currently have a GBX 1600.00 PT on the firm. JP Morgan Cazenove’s target means a potential upside of 9.22% from the company’s last close price.

Out of 16 analysts covering Smiths Group (LON:SMIN), 8 rate it a “Buy”, 2 “Sell”, while 6 “Hold”. This means 50% are positive. GBX 1600 is the highest target while GBX 780 is the lowest. The GBX 1185.33 average target is -19.09% below today’s (GBX 1465) stock price. Smiths Group has been the topic of 68 analyst reports since October 6, 2015 according to StockzIntelligence Inc. Beaufort Securities maintained the stock on September 29 with “Hold” rating. BNP Paribas maintained it with “Underperform” rating and GBX 1050 target price in a July 13 report. JP Morgan maintained the shares of SMIN in a report on August 30 with “Overweight” rating. Jefferies downgraded the firm’s rating on May 13. Jefferies has “Hold” rating and GBX 1200 price target. Lastly, RBC Capital Markets maintained the stock with “Outperform” rating in an August 10 report.

About 754,621 shares traded hands. Smiths Group plc (LON:SMIN) has risen 43.58% since March 1, 2016 and is uptrending. It has outperformed by 32.33% the S&P500.

Smiths Group plc is a technology company. The company has a market cap of 5.79 billion GBP. The Firm operates through five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. It has a 20.2 P/E ratio. John Crane division offers mechanical seals, seal support systems, engineered bearings, power transmission couplings and filtration systems.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment